Description

The FDA Advisory Committee met to discuss emergency use authorization for Pfizer’s COVID-19 vaccine in children ages five to 11 years old. In this portion, Dr. Dorian Fink, FDA Vaccines and Related Products Applications Deputy Director, presented various data and topics including the epidemiology of COVID-19 among children in this age group and post-COVID symptoms. The Committee later voted 17-0, with one abstention, to approve the emergency use authorization request.